You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SCTX Conversion Disclosure
Ah Bio Fund Ii, L.P. · SEC Form 4 · Filed Jul 29, 2026
Conversion
Calculated transaction value
$0
Ah Bio Fund Ii, L.P. 10% owner
SCTX
Transaction date
Jul 27, 2026
Public filing date
Jul 29, 2026
Filing lag
Filed 2 days later
SCTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series B Preferred Stock on Common Stock
- Quantity / price
- 4,131,344 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001231919-26-000813
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$5M
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Scribe Therapeutics, Inc. SCTX | Conversion | Jul 27, 2026 | Not reported |
| Scribe Therapeutics, Inc. SCTX | Buy | Jul 27, 2026 | $5M |
| Scribe Therapeutics, Inc. SCTX Current | Conversion | Jul 27, 2026 | $0 |
| Scribe Therapeutics, Inc. SCTX | Conversion | Jul 27, 2026 | Not reported |
| Scribe Therapeutics, Inc. SCTX | Conversion | Jul 27, 2026 | $0 |